Activity of cecropin P1 and FA-LL-37 against urogenital microflora

Microbes and Infection

Volumn 2, Issue 7, 2000, Pages 773-777

  Smeianov, Vladimir ^a   Scott, Kellie ^a   Reid, Gregor ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Antimicrobials; Peptides; Urogenital flora

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CECROPIN; CECROPIN P1; FA LL 37; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; URINARY TRACT INFECTION;

EID: 0033937030     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)90359-9     Document Type: Article

References (37)

1. Hultmark D., Steiner H., Rasmuson T., Boman H.G. Insect immunity: Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur. J. Biochem. 202:1980;7-16.
2. Agerberth B., Lee J.-Y., Bergman T., Carlquist M., Boman H.G., Mutt V., Jornvall H. Amino acid sequence of PR-39: isolation from pig intestine of a new member of the family of proline-arginine rich antibacterial peptides. Eur. J. Biochem. 265:1991;849-854.
3. Frank R.W., Gennaro R., Schneider K., Przybylski M., Romeo D. Amino acid sequence of two proline-rich bacteriocin antimicrobial peptides of bovine neutrophils. J. Biol. Chem. 86:1990;18871-18874.
4. Lee J.Y., Boman A., Chuanxin S., Andersson M., Jornvall H., Mutt V., Boman H.G. Antibacterial peptides form pig intestine: isolation of a mammalian cecropin. Proc. Natl. Acad. Sci. USA. 171:1989;9159-9162.
5. Lehrer R.I., Ganz T. Defensins: endogenous antibiotic peptides from human leukocytes. Ciba Found. Symp. 5:1992;276-293.
6. Ganz T., Lehrer R.I. Antibiotic peptides from higher eukaryotes:biology and applications. Mol. Med. Today. 13:1999;292-297.
7. Boman H.G. Peptide antibiotics and their role in innate immunity. Ann. Rev. Immunol. 186:1995;61-92.
8. Bevins C.L. Antimicrobial peptides as agents of mucosal immunity. Ciba Found. Symp. 272:1994;250-269.
9. Frohm M., Agerberth B., Ahangari G., Stahle-Backdahl M., Liden S., Wigzell H., Gudmundsson G.H. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 67:1997;15258-15263.
10. Frohm Nilsson M., Sandstedt B., Sorensen O., Weber G., Borregaard N., Stahlebackdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 226:1999;2366-2561.
11. Bernet-Camard M.F., Coconnier M.H., Hudault S., Servin A.L. Differentiation-associated antimicrobal functions in human colon adenocarcinoma cell lines. Exp. Cell Res. 6:1996;80-89.
12. Mc Groarty J.A. Probiotic use of lactobacilli in the human urogenital tract. FEMS Immunol. Med. Microbiol. 3:1993;251-264.
13. Reid G., Bruce A.W., Mc Groarty J.A., Cheng K.J., Costerton J.W. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin. Microbiol. Rev. 4:1990;335-344.
14. Kunin C.M. Detection, prevention and management of urinary tract infections. 4th Edition :1987;1-447 Lea and Febiger, Philadelphia.
15. Reid G., Seidenfeld A. Drug resistance amongst uropathogens isolated from women in a suburban population: Laboratory findings over 7 years. Can. J. Urol. 34:1997;432-437.
16. Bruce A.W., Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can. J. Microbiol. 108:1988;339-343.
17. Reid G., Smeianov V., Bruce A.W. Biotherapeutic agents to prevent cystitis in women. Elmer G.W, Mcfarland L.V, Surawicz C.M. Biotherapeutic Agents and Infectious Diseases. 1999;245-261 Humana Press, Totowa, New Jersey.
18. Bruce A.W., Chadwick P., Hassan A., Vancott G.F. Recurrent urethritis in women. Can. Med. Assoc. J. 22:1973;973-976.
19. Reid G., Bruce A.W., Cook R.L., Llano L.M. Effect on urogenital flora of antibiotic therapy for urinary tract infection. Scand. J. Infect. Dis. 37:1990;43-47.
20. Moore A.J., Beazley W.D., Bibby M.C., Devine D.A. Antimicrobial activity of cecropins. J. Antimicrob. Chemother. 65:1996;1077-1089.
21. Lee I.H., Cho Y., Lehrer R.I. Effect of pH and salinity on the antimicrobial properties of clavanins. Infect. Immun. 42:1997;2898-2903.
22. Giacometti A., Cirioni O., Greganti G., Quarta M., Scalise G. In vitro activities of membrane-active peptides against Gram-positive and Gram-negative aerobic bacteria. Antimicrob. Agents Chemother. 238:1998;3320-3324.
23. Gudmundsson G.H., Agerberth B., Odeberg J., Bergman T., Olsson B., Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 92:1996;325-332.
24. Agerberth B., Gunne H., Odeberg J., Kogner P., Boman H.G., Gudmundsson G.H. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA. 1:1995;195-199.
25. Larrick J.W., Hirata M., Zhong J., Wright S.C. Anti-microbial activity of human CAP18 peptides. Immunotechnology. 42:1995;65-72.
26. Turner J., Cho Y., Dinh N.N., Waring A.J., Lehrer R.I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 138:1998;2206-2214.
27. Reid G., Cook R.L., Bruce A.W. Examination of strains of lactobacilli for properties which may influence bacterial interference in the urinary tract. J. Urol. 43:1987;330-335.
28. Millsap K.W., Reid G., Van Der Mei H.C., Busscher H.J. Cluster analysis of genotypically characterized Lactobacillus species based of physicochemical cell surface properties and their relationship with adhesion to hexadecane. Can. J. Microbiol. 61:1997;284-291.
29. Boman H.G., Agerberth B., Boman A. Mechanisms of action on E. coli of cecropin P1 and PR-39, two antibacterial peptides form pig intestine. Infect. Immun. 34:1993;2978-2984.
30. Ahnalt J.P., Sabath L.D., Barry A.L. Special tests: Bactericidal activity, activity of antimicrobics in combination, and detection of â-lactamase production. Lennette E.H. Manual of Clinical Microbiology. 3th Edition :1980;478-490 American Society for Microbiology, Washington, DC.
31. Gazit E., Boman A., Boman H.G., Shai Y. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry. 341:1995;11479-11488.
32. Oren Z., Lerman J.C., Gudmunolson G.H., Agerberth B., Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 273:1999;501-513.
33. Johansson J., Gudmundsson G.H., Rottenberg M.E., Berndt K.D., Agerberth B. Conformation-dependent antibacterial activity of the naturally occuring human peptide LL-37. J. Biol. Chem. 64:1998;3718-3724.
34. Coleman M.S., Rabe L.K., Hillier S.L. In vitro activity of an antimicrobial peptide for use as a vaginal microbicide. Abstracts: 37th Interscience Conference on Antimicrob. Agents Chemother., F-44. 1997;American Society for Microbiology, Toronto, Canada.
35. Fontenot J.D., Burillo C.A., Mendonca V., Phillips D.M. Prevention of Chlamydia trachomatis infection by proline-rich antimicrobial peptides. Abstracts, 97th ASM General Meeting, B-414. 1997;American Society for Microbiology, Miami Beach, FL.
36. Qu X.D., Harwig S.S.L., Oren A., Shafer W.M., Lehrer R.I. Susceptibility of Neisseria gonorrhoeae to protegrins. Infect. Immun. 29:1996;1240-1245.
37. Mc Cormick J.K., Klaenhammer T.R., Stiles M.E. Colicin V can be produced by lactic acid bacteria. Lett. Appl. Microbiol. 1999;37-41.